Literature DB >> 10664533

Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications.

E Redenti1, L Szente, J Szejtli.   

Abstract

The objective of this mini-review is to summarize the findings concerning the properties and the pharmaceutical applications of multicomponent complexes made of a sparingly water-soluble amino-type drug, a cyclodextrin, and a hydroxy carboxylic acid. Simultaneous complexation and salt formation with these acids significantly increase the solubilizing power, allowing us to reduce the amount of cyclodextrin necessary for making the targeted formulation. In many cases, the aqueous solubility of the hydrophobic drug can be enhanced by several orders of magnitude, while that of CD can be enhanced more than 10-fold. The mechanism through which these complexes elicit their synergetic effects on the drug solubility is also discussed. Finally, some general observations are made concerning the structural requirements of the drug necessary for exploiting the aforementioned effect. Copyright 2000 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 89: 1-8, 2000

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10664533     DOI: 10.1002/(SICI)1520-6017(200001)89:1<1::AID-JPS1>3.0.CO;2-W

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique.

Authors:  Tijana Mihajlovic; Kyriakos Kachrimanis; Adrijana Graovac; Zorica Djuric; Svetlana Ibric
Journal:  AAPS PharmSciTech       Date:  2012-04-26       Impact factor: 3.246

2.  Carvedilol: solubilization and cyclodextrin complexation: a technical note.

Authors:  Thorsteinn Loftsson; Stine Byskov Vogensen; Cyrielle Desbos; Phatsawee Jansook
Journal:  AAPS PharmSciTech       Date:  2008-03-05       Impact factor: 3.246

3.  Interaction of artesunate with β-cyclodextrin: Characterization, thermodynamic parameters, molecular modeling, effect of PEG on complexation and antimalarial activity.

Authors:  Renu Chadha; Sushma Gupta; Geeta Shukla; D V S Jain; Raghuvir R S Pissurlenkar; Evans C Coutinho
Journal:  Results Pharma Sci       Date:  2011-08-04

Review 4.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

5.  Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.

Authors:  Kashappa Goud H Desai; Susan R Mallery; Steven P Schwendeman
Journal:  Eur J Pharm Biopharm       Date:  2008-03-20       Impact factor: 5.571

6.  Formation of fine drug particles by cogrinding with cyclodextrins. I. The use of beta-cyclodextrin anhydrate and hydrate.

Authors:  Arpansiree Wongmekiat; Yuichi Tozuka; Toshio Oguchi; Keiji Yamamoto
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

7.  Inclusion complexes of cefuroxime axetil with β-cyclodextrin: Physicochemical characterization, molecular modeling and effect of l-arginine on complexation.

Authors:  Sarika Sapte; Yogesh Pore
Journal:  J Pharm Anal       Date:  2016-04-01

8.  Multicomponent cyclodextrin system for improvement of solubility and dissolution rate of poorly water soluble drug.

Authors:  Mayank Patel; Rajashree Hirlekar
Journal:  Asian J Pharm Sci       Date:  2018-03-13       Impact factor: 6.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.